✦ LIBER ✦

A concise analytical strategy applied to waste treatment technology

✍ Scribed by S.R van der Laan; A van Vliet

Book ID: 117510411
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 883 KB
Volume: 62
Category: Article
ISSN: 0375-6742
DOI: 10.1016/s0375-6742(97)00065-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A path-analytic strategy to analyze psyc

A path-analytic strategy to analyze psychoanalytic treatment effects

✍ James Crouse; Anna Burton; Stephen Firestein; Robert D. Scharf; Sherwood Waldron 📂 Article 📅 2003 🏛 Institute of Psychoanalysis 🌐 English ⚖ 194 KB

Designing a Property Tax Reform Strategy

Designing a Property Tax Reform Strategy for Sub-Saharan Africa: An Analytical Framework Applied to Kenya

✍ Roy Kelly 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Treatment of Clinical Solid Waste Using

Treatment of Clinical Solid Waste Using a Steam Autoclave as a Possible Alternative Technology to Incineration

✍ Hossain, Md. Sohrab; Balakrishnan, Venugopal; Rahman, Nik Norulaini Nik Ab; Sark 📂 Article 📅 2012 🏛 MDPI AG 🌐 English ⚖ 462 KB

Modified cation exchange resin applied t

Modified cation exchange resin applied to demineralisation of a liquid industrial waste. Comparison to a classical treatment and electrodialysis

✍ Mourad Amara; Hacène Kerdjoudj 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Advanced aspects of thermal treatment of

Advanced aspects of thermal treatment of solid wastes: From a flue gas to a fuel gas technology?

✍ Umberto Arena; Michael Nelles; Joachim Werther 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 191 KB

From Theory to Practice: Applying Curren

From Theory to Practice: Applying Current Clinical Knowledge and Treatment Strategies to the Care of Hemophilia A Patients With Inhibitors

✍ Edward D. Gomperts; Jan Astermark; Alessandro Gringeri; Jerome Teitel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 666 KB

Two bypassing agents are currently available to circumvent the need for factor FVIII in hemophilia A patients with inhibitors: the activated prothrombin complex FEIBA VH and recombinant activated factor VII (NovoSeven ® ). Both products are highly effective in controlling bleeding in the presence of